LMNB2 — 679 ClinVar variants
All ClinVar germline LMNB2 variants across every classification, each assembled from ClinVar, gnomAD, AlphaMissense, conservation and more. 310 flagged for review →
4 Pathogenic · 27 Conflicting · 47 Benign · 15 Benign/Likely benign · 275 Likely benign · 311 Uncertain significance
Full LMNB2 gene report on Sugi Atlas → Gene function, pathways, protein structure, constraint & interactions⚑ Evidence disagreements 310
Variants where the independent computational evidence doesn't line up with the clinical picture — a QC signal for a second look, not a reclassification.
Predictors vs ClinVar 1
ClinVar calls these pathogenic, but the computational predictors lean tolerated — the highest-value review flag.
-
LMNB2 p.His157Tyr
Pathogenic
No assertion criteria
progressive myoclonic epilepsy type 9
Predictors agree, ClinVar conflicts 17
ClinVar submitters conflict, but the independent predictors unanimously agree — a QC review flag, not a reclassification.
-
LMNB2 p.Ala192Ser
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala355Thr
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ala94Val
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg171His
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg411His
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg561His
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg584Cys
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Asn132Ser
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Asp253Asn
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Asp333Glu
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gln250His
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly599Asp
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Leu353Met
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ser559Arg
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Thr233Met
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Tyr618His
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Val582Met
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
Predictors lean, ClinVar uncertain 194
ClinVar classifies these uncertain (VUS), but the independent predictors unanimously lean one way — a triage signal for review, not a reclassification. · showing the 150 best-reviewed of 194
-
LMNB2 p.Ala178Thr
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala299Val
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala29Pro
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ala567Thr
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg104Gly
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg158Gln
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg181Gln
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg239Gln
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg240His
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg350Gln
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg524His
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Asp268Asn
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Asp287Asn
Uncertain significance
Multiple submitters
microcephaly 27, primary, autosomal dominant
-
LMNB2 p.Asp297Asn
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Asp297Glu
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu188Lys
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu232Lys
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu251Asp
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu597Lys
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly190Ser
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gly323Ser
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gly397Asp
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly510Arg
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.His191Arg
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Lys489Gln
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Pro542Ser
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ser134Arg
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ser247Arg
Uncertain significance
Multiple submitters
LMNB2-related disorder
-
LMNB2 p.Ser419Leu
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ser5Ile
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Val412Ile
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Val474Ile
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Val563Ile
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Val565Leu
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala101Val
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ala111Ser
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala135Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Ala165Pro Uncertain significance Single submitter
-
LMNB2 p.Ala165Ser
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ala17Ser
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala18Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala192Val
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Ala303Thr Uncertain significance Single submitter
-
LMNB2 p.Ala331Thr
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Ala390Thr Uncertain significance Single submitter
-
LMNB2 p.Ala427Ser
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Ala465Thr Uncertain significance Single submitter
-
LMNB2 p.Ala468Thr
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ala514Thr
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala536Thr
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ala539Thr
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala596Gly
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala94Gly
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg104Gln
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg104Leu
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg104Trp
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg10Leu
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg10Pro
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg116Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg14Gly
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg205Cys
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg222Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg231Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg234Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg236Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Arg313His Uncertain significance Single submitter
- LMNB2 p.Arg336Pro Uncertain significance Single submitter
-
LMNB2 p.Arg346Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg364Trp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg40Leu
Uncertain significance
Single submitter
neurodevelopmental disorder
-
LMNB2 p.Arg416Gln
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg430His
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg505Ser
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Arg51Cys Uncertain significance Single submitter
- LMNB2 p.Arg584Ser Uncertain significance Single submitter
- LMNB2 p.Arg73Pro Uncertain significance Single submitter
-
LMNB2 p.Arg8His
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Asn296His
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Asn586Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Asp169Asn Uncertain significance Single submitter
-
LMNB2 p.Asp220Gly
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Asp347Glu
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Asp602Asn Uncertain significance Single submitter
-
LMNB2 p.Asp609Tyr
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gln12Pro
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gln146Arg
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gln249Lys
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Gln280His Uncertain significance Single submitter
-
LMNB2 p.Gln283Glu
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Gln369Arg Uncertain significance Single submitter
- LMNB2 p.Gln466His Uncertain significance Single submitter
- LMNB2 p.Gln506Glu Uncertain significance Single submitter
- LMNB2 p.Gln527His Uncertain significance Single submitter
-
LMNB2 p.Glu130Lys
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu238Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu243Gly
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu279Val
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Glu339Val
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Glu345Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu442Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu478Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu482Lys
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu49Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu585Ala
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu585Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu587Ala
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu600Lys
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu97Lys
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly140Ser
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly190Arg
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly344Arg
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly423Ser
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gly423Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gly429Arg
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Gly432Ser Uncertain significance Single submitter
-
LMNB2 p.Gly446Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gly446Ser
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Gly448Ser Uncertain significance Single submitter
-
LMNB2 p.Gly457Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gly457Ser
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly499Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Gly535Asp Uncertain significance Single submitter
-
LMNB2 p.Gly535Ser
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly569Asp
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly616Val
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.His59Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ile388Ser
Uncertain significance
Single submitter
microcephaly 27, primary, autosomal dominant
- LMNB2 p.Ile479Met Uncertain significance Single submitter
-
LMNB2 p.Ile522Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Leu152Met
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Leu167Val
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Leu25Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Leu314Met
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Leu317Phe
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Leu425Phe Uncertain significance Single submitter
-
LMNB2 p.Leu53Phe
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Leu76Val Uncertain significance Single submitter
-
LMNB2 p.Lys186Met
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Lys285Arg Uncertain significance Single submitter
- LMNB2 p.Lys326Glu Uncertain significance Single submitter
-
LMNB2 p.Lys381Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Lys484Gln
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Lys494Thr
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Lys549Asn Uncertain significance Single submitter
- LMNB2 p.Met312Val Uncertain significance Single submitter
-
LMNB2 p.Met342Ile
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Met352Lys
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Met386Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Met574Leu Uncertain significance Single submitter
-
LMNB2 p.Met574Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
Predictors split 98
The independent predictors disagree with each other — read with care.
-
LMNB2 p.Arg114His
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg148Cys
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg148His
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg211Cys
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg231Trp
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg239Trp
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg248Gln
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg248Trp
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg304Cys
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg304His
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg311His
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg336Trp
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg430Cys
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg524Cys
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Asp220His
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Glu141Lys
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu269Lys
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Glu376Gln
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Glu593Gln
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gly448Cys
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Lys308Glu
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Phe349Leu
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Pro24Gln
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ser405Phe
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ser407Arg
Uncertain significance
Multiple submitters
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ser544Leu
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Thr110Met
Uncertain significance
Multiple submitters
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala115Gly
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ala257Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Ala259Val Uncertain significance Single submitter
-
LMNB2 p.Ala417Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala468Gly
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ala470Thr
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala470Val
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala533Thr
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ala536Val
Likely benign
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Ala567Val
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg112Gln
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg114Cys
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Arg116Trp Uncertain significance Single submitter
-
LMNB2 p.Arg158Trp
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg171Cys
Likely benign
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg171Leu
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg181Trp
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg211His
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Arg231Gly Uncertain significance Single submitter
-
LMNB2 p.Arg234Trp
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg272Leu
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg272Trp
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg311Cys
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg336Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg364Gln
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg433Cys
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg433His
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg438Gln
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Arg438Trp
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Arg87His
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Asn71Lys Uncertain significance Single submitter
-
LMNB2 p.Asp245Asn
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Gln213Arg Uncertain significance Single submitter
-
LMNB2 p.Glu113Gly
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Glu199Gly
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Glu229Asp
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Glu238Lys
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Glu477Lys
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Glu478Ala Uncertain significance Single submitter
-
LMNB2 p.Glu512Gly
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Glu570Lys
Likely benign
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Gly423Cys Uncertain significance Single submitter
-
LMNB2 p.Gly510Trp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Gly526Ser
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly550Arg
Uncertain significance
Single submitter
LMNB2-related disorder
-
LMNB2 p.Gly608Arg
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Gly91Asp
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Leu173Met
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Leu198Met
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Leu95Arg
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
- LMNB2 p.Lys223Asn Uncertain significance Single submitter
-
LMNB2 p.Lys489Asn
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Ser318Ile Uncertain significance Single submitter
-
LMNB2 p.Ser322Phe
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ser419Trp
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Ser42Leu Uncertain significance Single submitter
-
LMNB2 p.Ser469Leu
Conflicting
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ser471Leu
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ser492Leu
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
- LMNB2 p.Ser497Phe Likely benign Single submitter
-
LMNB2 p.Ser541Arg
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ser553Arg
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ser553Ile
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Ser79Leu
Uncertain significance
Single submitter
neurodevelopmental disorder
-
LMNB2 p.Ser98Leu
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Thr202Met
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Thr34Met
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Thr518Met
Conflicting
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Thr530Met
Uncertain significance
Single submitter
progressive myoclonic epilepsy type 9
-
LMNB2 p.Thr545Met
Uncertain significance
Single submitter
lipodystrophy, partial, acquired, susceptibility to
-
LMNB2 p.Val538Leu
Benign
Single submitter
lipodystrophy, partial, acquired, susceptibility to
All LMNB2 variants
Pathogenic 4
- p.Glu398Lys Multiple submitters LMNB2-related disorder
- p.Val193fs Single submitter microcephaly 27, primary, autosomal dominant
- p.Asn54His No assertion criteria microcephaly 27, primary, autosomal dominant
- p.His157Tyr No assertion criteria progressive myoclonic epilepsy type 9 ⚠
Conflicting classifications of pathogenicity 27
- c.265-19C>T Single submitter progressive myoclonic epilepsy type 9
- p.Ala192Ser Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala355Thr Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala468Gly Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala94Val Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg171His Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg234Trp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg411His Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg433His Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg438Trp Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg561His Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg584Cys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Asn132Ser Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Asp253Asn Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Asp333Glu Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gln250His Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Glu339Ala Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu512Gly Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly599Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Leu353Met Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser469Leu Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser492Leu Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser559Arg Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Thr233Met Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Thr518Met Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Tyr618His Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Val582Met Single submitter progressive myoclonic epilepsy type 9 ⚠
Benign 47
- c.1202+48A>G Multiple submitters
- c.1482+16G>A Multiple submitters progressive myoclonic epilepsy type 9
- c.1483-34T>C Multiple submitters
- c.1590+14C>T Multiple submitters progressive myoclonic epilepsy type 9
- c.1590+71A>G Multiple submitters
- c.265-27G>A Multiple submitters
- c.265-70C>T Multiple submitters
- c.401+39T>C Multiple submitters
- c.402-136G>A Multiple submitters
- c.402-149G>T Multiple submitters
- c.684+42G>A Multiple submitters
- c.856-30G>A Multiple submitters
- c.982-38T>C Multiple submitters
- c.*272G>C Multiple submitters
- p.Ala19Thr Multiple submitters progressive myoclonic epilepsy type 9
- c.1482+11A>T Single submitter progressive myoclonic epilepsy type 9
- c.1482+15C>T Single submitter progressive myoclonic epilepsy type 9
- c.1482+20C>T Single submitter progressive myoclonic epilepsy type 9
- c.1483-182A>G Single submitter
- c.1483-20G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1483-260G>A Single submitter
- c.1590+237G>A Single submitter
- c.1591-173C>T Single submitter
- c.1711-3C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1821+274A>C Single submitter
- c.1821+291C>T Single submitter
- c.1821+4G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1822-220C>T Single submitter
- c.264+260G>T Single submitter
- c.265-224C>T Single submitter
- c.265-295G>A Single submitter
- c.402-262G>C Single submitter
- c.402-272A>G Single submitter
- c.684+163G>A Single submitter
- c.685-165C>T Single submitter
- c.685-287A>G Single submitter
- c.685-5C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.856-14C>G Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ala135Thr Single submitter progressive myoclonic epilepsy type 9
- p.Ala427Thr Single submitter progressive myoclonic epilepsy type 9
- p.Arg561Cys Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg561Leu Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg584His Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Leu208= Single submitter progressive myoclonic epilepsy type 9
- p.Met583Ile Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Pro4Leu Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Val538Leu Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
Benign/Likely benign 15
- c.1483-11G>A Multiple submitters progressive myoclonic epilepsy type 9
- c.1483-12C>T Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- c.1711-7C>T Multiple submitters progressive myoclonic epilepsy type 9
- c.1822-17T>C Multiple submitters progressive myoclonic epilepsy type 9
- c.855+8C>T Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Arg235Gln Multiple submitters microcephaly 27, primary, autosomal dominant
- p.Arg416Leu Multiple submitters progressive myoclonic epilepsy type 9
- p.Asp268= Multiple submitters progressive myoclonic epilepsy type 9
- p.Gly172Ser Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Gly460Ser Multiple submitters progressive myoclonic epilepsy type 9
- p.Gly472= Multiple submitters progressive myoclonic epilepsy type 9
- p.Ser134= Multiple submitters progressive myoclonic epilepsy type 9
- p.Ser469= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Thr85= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Tyr96= Multiple submitters progressive myoclonic epilepsy type 9
Likely benign 275
- c.1203-17_1203-14del Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- c.1483-4C>T Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- c.1821+7C>A Multiple submitters progressive myoclonic epilepsy type 9
- c.1822-20TCCT[3] Multiple submitters progressive myoclonic epilepsy type 9
- c.1822-20TCCT[5] Multiple submitters progressive myoclonic epilepsy type 9
- c.559-20C>T Multiple submitters progressive myoclonic epilepsy type 9
- c.982-15C>A Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- c.982-4G>A Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- c.982-5C>T Multiple submitters progressive myoclonic epilepsy type 9
- c.982-8C>T Multiple submitters progressive myoclonic epilepsy type 9
- p.Ala302= Multiple submitters progressive myoclonic epilepsy type 9
- p.Ala525= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Ala536= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Ala596= Multiple submitters progressive myoclonic epilepsy type 9
- p.Ala94= Multiple submitters progressive myoclonic epilepsy type 9
- p.Arg114= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Arg205= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Arg222= Multiple submitters progressive myoclonic epilepsy type 9
- p.Arg272Gln Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Arg28= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Arg524= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Asn389= Multiple submitters progressive myoclonic epilepsy type 9
- p.Asp176= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Asp189= Multiple submitters progressive myoclonic epilepsy type 9
- p.Asp379= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Glu160= Multiple submitters progressive myoclonic epilepsy type 9
- p.Gly455= Multiple submitters progressive myoclonic epilepsy type 9
- p.Gly455Arg Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Ile479= Multiple submitters progressive myoclonic epilepsy type 9
- p.Pro543= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Pro6= Multiple submitters progressive myoclonic epilepsy type 9
- p.Pro610= Multiple submitters progressive myoclonic epilepsy type 9
- p.Ser214= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Ser37= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Ser410= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Ser426= Multiple submitters progressive myoclonic epilepsy type 9
- p.Ser447= Multiple submitters progressive myoclonic epilepsy type 9
- p.Ser450= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Ser581= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Ser581Leu Multiple submitters progressive myoclonic epilepsy type 9
- p.Thr110= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Thr233= Multiple submitters progressive myoclonic epilepsy type 9
- p.Thr456= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Thr518= Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Tyr618= Multiple submitters progressive myoclonic epilepsy type 9
- p.Val206= Multiple submitters progressive myoclonic epilepsy type 9
- c.1202+10G>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1202+4C>T Single submitter progressive myoclonic epilepsy type 9
- c.1203-13G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1203-16C>T Single submitter progressive myoclonic epilepsy type 9
- c.1203-17C>G Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1482+12G>C Single submitter progressive myoclonic epilepsy type 9
- c.1482+17G>C Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1482+19G>A Single submitter progressive myoclonic epilepsy type 9
- c.1482+7G>A Single submitter progressive myoclonic epilepsy type 9
- c.1483-7C>T Single submitter progressive myoclonic epilepsy type 9
- c.1590+15A>G Single submitter
- c.1591-8G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1710+14G>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1710+18G>C Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1710+18G>T Single submitter
- c.1710+7G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1710+7G>T Single submitter progressive myoclonic epilepsy type 9
- c.1711-11G>A Single submitter progressive myoclonic epilepsy type 9
- c.1711-16G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1711-16G>T Single submitter progressive myoclonic epilepsy type 9
- c.1711-18G>A Single submitter progressive myoclonic epilepsy type 9
- c.1711-19C>T Single submitter progressive myoclonic epilepsy type 9
- c.1711-6G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1711-8C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1821+13T>C Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1821+14G>A Single submitter
- c.1821+15C>G Single submitter progressive myoclonic epilepsy type 9
- c.1821+15C>T Single submitter progressive myoclonic epilepsy type 9
- c.1821+16C>T Single submitter progressive myoclonic epilepsy type 9
- c.1821+8C>T Single submitter progressive myoclonic epilepsy type 9
- c.1822-10C>G Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1822-20T>C Single submitter
- c.1822-20TCCT[6] Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.264+15T>C Single submitter progressive myoclonic epilepsy type 9
- c.264+7G>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.264+9del Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.265-6C>T Single submitter progressive myoclonic epilepsy type 9
- c.401+12C>T Single submitter progressive myoclonic epilepsy type 9
- c.401+13G>A Single submitter progressive myoclonic epilepsy type 9
- c.558+18C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.558+19G>A Single submitter progressive myoclonic epilepsy type 9
- c.558+20_558+24del Single submitter progressive myoclonic epilepsy type 9
- c.559-12T>C Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.559-14C>T Single submitter progressive myoclonic epilepsy type 9
- c.559-19G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.559-5C>G Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.559-7C>T Single submitter progressive myoclonic epilepsy type 9
- c.684+10T>C Single submitter progressive myoclonic epilepsy type 9
- c.684+14C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.684+15T>G Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.684+20T>C Single submitter progressive myoclonic epilepsy type 9
- c.685-18C>T Single submitter progressive myoclonic epilepsy type 9
- c.685-4G>A Single submitter progressive myoclonic epilepsy type 9
- c.685-8G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.855+11C>A Single submitter
- c.855+12A>G Single submitter
- c.855+14G>A Single submitter progressive myoclonic epilepsy type 9
- c.855+15C>G Single submitter
- c.855+16G>A Single submitter progressive myoclonic epilepsy type 9
- c.855+19T>G Single submitter
- c.855+9G>T Single submitter progressive myoclonic epilepsy type 9
- c.856-10C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.856-12G>A Single submitter progressive myoclonic epilepsy type 9
- c.856-13C>T Single submitter progressive myoclonic epilepsy type 9
- c.856-13del Single submitter progressive myoclonic epilepsy type 9
- c.856-16G>A Single submitter progressive myoclonic epilepsy type 9
- c.856-17C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.856-6C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.856-8C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.981+14C>A Single submitter progressive myoclonic epilepsy type 9
- c.981+14C>T Single submitter progressive myoclonic epilepsy type 9
- c.981+15G>A Single submitter progressive myoclonic epilepsy type 9
- c.981+20C>T Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.982-10C>T Single submitter
- c.982-11C>T Single submitter progressive myoclonic epilepsy type 9
- c.982-12C>T Single submitter progressive myoclonic epilepsy type 9
- c.982-13G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.982-20G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.982-4G>C Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.982-4G>T Single submitter progressive myoclonic epilepsy type 9
- c.982-9C>T Single submitter progressive myoclonic epilepsy type 9
- p.Ala101= Single submitter progressive myoclonic epilepsy type 9
- p.Ala103= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ala164= Single submitter progressive myoclonic epilepsy type 9
- p.Ala17= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ala185= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ala187= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ala194= Single submitter progressive myoclonic epilepsy type 9
- p.Ala194Pro Single submitter progressive myoclonic epilepsy type 9
- p.Ala22= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ala259= Single submitter progressive myoclonic epilepsy type 9
- p.Ala343= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ala372= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ala417= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ala468= Single submitter progressive myoclonic epilepsy type 9
- p.Ala514= Single submitter
- p.Ala536Val Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala567= Single submitter progressive myoclonic epilepsy type 9
- p.Ala66= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg116= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg171= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg171Cys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg304= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg411= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg411Cys Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg416= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg51= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg65= Single submitter progressive myoclonic epilepsy type 9
- p.Arg8Cys Single submitter progressive myoclonic epilepsy type 9
- p.Arg9= Single submitter progressive myoclonic epilepsy type 9
- p.Arg9Cys Single submitter progressive myoclonic epilepsy type 9
- p.Asn296= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Asn566= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Asp129= Single submitter progressive myoclonic epilepsy type 9
- p.Asp220= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Asp347= Single submitter progressive myoclonic epilepsy type 9
- p.Asp354= Single submitter progressive myoclonic epilepsy type 9
- p.Asp602= Single submitter
- p.Gln266= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Gln527= Single submitter progressive myoclonic epilepsy type 9
- p.Glu127= Single submitter progressive myoclonic epilepsy type 9
- p.Glu139= Single submitter progressive myoclonic epilepsy type 9
- p.Glu199= Single submitter progressive myoclonic epilepsy type 9
- p.Glu232= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu243= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu269Asp Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu309= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu339= Single submitter progressive myoclonic epilepsy type 9
- p.Glu359= Single submitter
- p.Glu387= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu399= Single submitter progressive myoclonic epilepsy type 9
- p.Glu46= Single submitter progressive myoclonic epilepsy type 9
- p.Glu477= Single submitter progressive myoclonic epilepsy type 9
- p.Glu482= Single submitter progressive myoclonic epilepsy type 9
- p.Glu509= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu509Asp Single submitter
- p.Glu52= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu570Lys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu592= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu83= Single submitter progressive myoclonic epilepsy type 9
- p.Glu97= Single submitter progressive myoclonic epilepsy type 9
- p.Gly140= Single submitter progressive myoclonic epilepsy type 9
- p.Gly147Asp Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Gly172= Single submitter progressive myoclonic epilepsy type 9
- p.Gly323= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Gly432= Single submitter
- p.Gly448= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Gly526= Single submitter progressive myoclonic epilepsy type 9
- p.Gly569= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Gly599= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Gly608= Single submitter
- p.Gly91= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.His237= Single submitter progressive myoclonic epilepsy type 9
- p.His267= Single submitter progressive myoclonic epilepsy type 9
- p.His463= Single submitter progressive myoclonic epilepsy type 9
- p.Ile476= Single submitter progressive myoclonic epilepsy type 9
- p.Ile513= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ile61= Single submitter
- p.Leu117= Single submitter progressive myoclonic epilepsy type 9
- p.Leu163= Single submitter progressive myoclonic epilepsy type 9
- p.Leu203= Single submitter progressive myoclonic epilepsy type 9
- p.Leu215= Single submitter progressive myoclonic epilepsy type 9
- p.Leu219= Single submitter
- p.Leu25= Single submitter progressive myoclonic epilepsy type 9
- p.Leu273= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Leu286= Single submitter
- p.Leu314= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Leu338Met Single submitter progressive myoclonic epilepsy type 9
- p.Leu402= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Leu452= Single submitter progressive myoclonic epilepsy type 9
- p.Leu464= Single submitter progressive myoclonic epilepsy type 9
- p.Leu488= Single submitter
- p.Leu50= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Leu523= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Leu74= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Leu76= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Lys200= Single submitter
- p.Lys579Asn Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Met528Leu Single submitter progressive myoclonic epilepsy type 9
- p.Phe517= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Phe598Ser Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Pro15= Single submitter progressive myoclonic epilepsy type 9
- p.Pro32= Single submitter progressive myoclonic epilepsy type 9
- p.Pro444= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Pro449= Single submitter progressive myoclonic epilepsy type 9
- p.Pro4Ser Single submitter progressive myoclonic epilepsy type 9
- p.Ser168= Single submitter progressive myoclonic epilepsy type 9
- p.Ser2= Single submitter progressive myoclonic epilepsy type 9
- p.Ser246= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ser288= Single submitter progressive myoclonic epilepsy type 9
- p.Ser2Asn Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ser301= Single submitter progressive myoclonic epilepsy type 9
- p.Ser322= Single submitter progressive myoclonic epilepsy type 9
- p.Ser419= Single submitter progressive myoclonic epilepsy type 9
- p.Ser422= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ser459= Single submitter progressive myoclonic epilepsy type 9
- p.Ser471= Single submitter progressive myoclonic epilepsy type 9
- p.Ser492= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ser497Phe Single submitter ⚠
- p.Ser5= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ser541= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ser544= Single submitter progressive myoclonic epilepsy type 9
- p.Ser580= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ser614= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Ser98= Single submitter progressive myoclonic epilepsy type 9
- p.Thr143= Single submitter progressive myoclonic epilepsy type 9
- p.Thr143Met Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Thr20Ile Single submitter progressive myoclonic epilepsy type 9
- p.Thr23= Single submitter progressive myoclonic epilepsy type 9
- p.Thr281= Single submitter progressive myoclonic epilepsy type 9
- p.Thr361= Single submitter progressive myoclonic epilepsy type 9
- p.Thr413= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Thr428= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Thr454Met Single submitter progressive myoclonic epilepsy type 9
- p.Thr530= Single submitter progressive myoclonic epilepsy type 9
- p.Thr545= Single submitter progressive myoclonic epilepsy type 9
- p.Thr562= Single submitter progressive myoclonic epilepsy type 9
- p.Tyr515= Single submitter progressive myoclonic epilepsy type 9
- p.Tyr521= Single submitter progressive myoclonic epilepsy type 9
- p.Val131Ala Single submitter
- p.Val177Met Single submitter progressive myoclonic epilepsy type 9
- p.Val242= Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Val412= Single submitter progressive myoclonic epilepsy type 9
- p.Val451Ile Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Val84= Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1203-7C>G No assertion criteria LMNB2-related disorder
- c.*2C>A No assertion criteria LMNB2-related disorder
- c.*9_*21del No assertion criteria LMNB2-related disorder
- p.Val577= No assertion criteria LMNB2-related disorder
Uncertain significance 311
Showing the top 300 by review status; the full set is in the sitemap.
- c.1202+5G>A Multiple submitters progressive myoclonic epilepsy type 9
- p.Ala178Thr Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Ala299Val Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Ala29Pro Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala567Thr Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg104Gly Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg114His Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg148Cys Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg148His Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg158Gln Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Arg181Gln Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg205His Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Arg211Cys Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Arg211Leu Multiple submitters lipodystrophy, partial, acquired, susceptibility to
- p.Arg231Trp Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg239Gln Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Arg239Trp Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Arg240His Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg248Gln Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Arg248Trp Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg304Cys Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Arg304His Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg311His Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Arg336Trp Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg350Gln Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Arg430Cys Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg438Leu Multiple submitters progressive myoclonic epilepsy type 9
- p.Arg524Cys Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg524His Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg9His Multiple submitters microcephaly 27, primary, autosomal dominant
- p.Asp220His Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Asp268Asn Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Asp287Asn Multiple submitters microcephaly 27, primary, autosomal dominant ⚠
- p.Asp297Asn Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Asp297Glu Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Glu141Lys Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Glu188Lys Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Glu232Lys Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Glu251Asp Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Glu269Lys Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Glu376Gln Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Glu593Gln Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Glu597Lys Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly190Ser Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Gly323Ser Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Gly397Asp Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly448Cys Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Gly510Arg Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.His191Arg Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Lys308Glu Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Lys489Gln Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Phe349Leu Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Pro24Gln Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Pro542Ser Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Ser134Arg Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser247Arg Multiple submitters LMNB2-related disorder ⚠
- p.Ser405Phe Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser407Arg Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser419Leu Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Ser544Leu Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Ser5Ile Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Thr110Met Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Val412Ile Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Val474Ile Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- p.Val563Ile Multiple submitters lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Val565Leu Multiple submitters progressive myoclonic epilepsy type 9 ⚠
- c.1202+4C>G Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.1203-14T>A Single submitter progressive myoclonic epilepsy type 9
- c.1482+6C>T Single submitter progressive myoclonic epilepsy type 9
- c.1711-6G>C Single submitter
- c.264+5G>T Single submitter progressive myoclonic epilepsy type 9
- c.402-18_402-3del Single submitter progressive myoclonic epilepsy type 9
- c.558+5G>A Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.559-2A>G Single submitter lipodystrophy, partial, acquired, susceptibility to
- c.684+1G>A Single submitter progressive myoclonic epilepsy type 9
- c.684+3G>A Single submitter progressive myoclonic epilepsy type 9
- c.685-6C>A Single submitter progressive myoclonic epilepsy type 9
- c.855+15C>T Single submitter progressive myoclonic epilepsy type 9
- p.Ala101Val Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala111Ser Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala115Gly Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala135Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala165Pro Single submitter ⚠
- p.Ala165Ser Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala17Ser Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala18Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala192Val Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala257Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala259Val Single submitter ⚠
- p.Ala303Thr Single submitter ⚠
- p.Ala331Thr Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala390Thr Single submitter ⚠
- p.Ala417Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala427Ser Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala465Thr Single submitter ⚠
- p.Ala468Thr Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala470Thr Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala470Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala514Thr Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala533Thr Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala536Thr Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala539Thr Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala567Val Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ala596Gly Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ala94Gly Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg104Gln Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg104Leu Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg104Trp Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg10Leu Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg10Pro Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg112Gln Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg114Cys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg116Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg116Trp Single submitter ⚠
- p.Arg13Cys Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg14fs Single submitter
- p.Arg14Gly Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg158Trp Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg171Leu Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg181Trp Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg205Cys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg211His Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg222Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg231Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg231Gly Single submitter ⚠
- p.Arg234Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg236_Arg240del Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Arg236Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg272Leu Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg272Trp Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg311Cys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg313His Single submitter ⚠
- p.Arg336Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg336Pro Single submitter ⚠
- p.Arg346Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg364Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg364Trp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg40Leu Single submitter neurodevelopmental disorder ⚠
- p.Arg416Gln Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg430His Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg433Cys Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Arg438Gln Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg505Ser Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg51Cys Single submitter ⚠
- p.Arg584Ser Single submitter ⚠
- p.Arg73Pro Single submitter ⚠
- p.Arg87His Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Arg8His Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Asn132Ile Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Asn296His Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Asn586Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Asn71Lys Single submitter ⚠
- p.Asp169Asn Single submitter ⚠
- p.Asp220Gly Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Asp245Asn Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Asp253del Single submitter progressive myoclonic epilepsy type 9
- p.Asp297del Single submitter microcephaly 27, primary, autosomal dominant
- p.Asp347Glu Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Asp602Asn Single submitter ⚠
- p.Asp609Tyr Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gln12Pro Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gln146Arg Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gln213Arg Single submitter ⚠
- p.Gln249Lys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gln258Ter Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Gln280His Single submitter ⚠
- p.Gln283Glu Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gln369Arg Single submitter ⚠
- p.Gln45Ter Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Gln466His Single submitter ⚠
- p.Gln506Glu Single submitter ⚠
- p.Gln527His Single submitter ⚠
- p.Glu113Gly Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu130Lys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu153Lys Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu199Gly Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Glu229Asp Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Glu238Lys Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Glu238Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu243Gly Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu279Val Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Glu306Ter Single submitter
- p.Glu339Val Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Glu345Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu400Ter Single submitter lipodystrophy, partial, acquired, susceptibility to
- p.Glu442Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu477Lys Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Glu478Ala Single submitter ⚠
- p.Glu478Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu482Lys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu49Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu585Ala Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu585Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu587Ala Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu595del Single submitter progressive myoclonic epilepsy type 9
- p.Glu600Lys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Glu97Lys Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly140Ser Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly190Arg Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly344Arg Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly423Cys Single submitter ⚠
- p.Gly423Ser Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gly423Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gly429Arg Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gly432Ser Single submitter ⚠
- p.Gly446Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gly446Ser Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gly448Ser Single submitter ⚠
- p.Gly457Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gly457Ser Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly499Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gly510Trp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Gly526Ser Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly535Asp Single submitter ⚠
- p.Gly535Ser Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly550Arg Single submitter LMNB2-related disorder ⚠
- p.Gly569Asp Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly608Arg Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly616Val Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Gly91Asp Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.His540fs Single submitter progressive myoclonic epilepsy type 9
- p.His59Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ile388Ser Single submitter microcephaly 27, primary, autosomal dominant ⚠
- p.Ile479Met Single submitter ⚠
- p.Ile522Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Leu152Met Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Leu167Val Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Leu173Met Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Leu198Met Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Leu25Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Leu314Met Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Leu317Phe Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Leu425Phe Single submitter ⚠
- p.Leu53Phe Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Leu76Val Single submitter ⚠
- p.Leu95Arg Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Lys186Met Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Lys223Asn Single submitter ⚠
- p.Lys285Arg Single submitter ⚠
- p.Lys326Glu Single submitter ⚠
- p.Lys381Gln Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Lys484Gln Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Lys489Asn Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Lys494Thr Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Lys549Asn Single submitter ⚠
- p.Met312Val Single submitter ⚠
- p.Met342Ile Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Met352Lys Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Met386Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Met574Leu Single submitter ⚠
- p.Met574Val Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Met620Thr Single submitter ⚠
- p.Pro38Leu Single submitter ⚠
- p.Pro3Leu Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Pro406Thr Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Pro542Thr Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Pro543Arg Single submitter ⚠
- p.Pro610Leu Single submitter ⚠
- p.Pro6Ala Single submitter ⚠
- p.Pro6Ser Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser159Arg Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser168Asn Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser246Gly Single submitter ⚠
- p.Ser288Asn Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser301Ile Single submitter ⚠
- p.Ser318Ile Single submitter ⚠
- p.Ser322Phe Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser407Thr Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser410Leu Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser415Leu Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser419Trp Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser42Leu Single submitter ⚠
- p.Ser434Arg Single submitter ⚠
- p.Ser447Gly Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser450Arg Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Ser471Leu Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser473Gly Single submitter ⚠
- p.Ser541Arg Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser544fs Single submitter
- p.Ser553Arg Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser553Ile Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser5Asn Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Ser79Leu Single submitter neurodevelopmental disorder ⚠
- p.Ser98Leu Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Thr202Met Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Thr281Ile Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Thr34Met Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Thr34Pro Single submitter ⚠
- p.Thr361Met Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Thr418Ile Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Thr418Pro Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Thr454Arg Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Thr456Met Single submitter ⚠
- p.Thr530Met Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Thr545Met Single submitter lipodystrophy, partial, acquired, susceptibility to ⚠
- p.Thr556Met Single submitter ⚠
- p.Thr576Ala Single submitter ⚠
- p.Thr612Ile Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Thr86Met Single submitter progressive myoclonic epilepsy type 9 ⚠
- p.Tyr319His Single submitter progressive myoclonic epilepsy type 9 ⚠